Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of Multiple Doses of JS002 in Patients With Hyperlipidemia.. [Phase 1, Phase 2]
Phase 1/2 trial investigating multiple doses of JS002 for hyperlipidemia completed.
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: Biosynthesis of PGD2 in Vivo [NA]
This clinical trial investigated in vivo biosynthesis of prostaglandin D2 (PGD2) in people with hyperlipidemia. The study has completed and …
-
FDA approval · 2020-06-24FDA Approved: PITAVASTATIN — Supplemental Application (Aurobindo Pharma Limited)
FDA granted a supplemental approval for a generic pitavastatin product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia [Phase 2]
Phase 2 clinical trial update evaluating CVI-LM001 for hyperlipidemia; safety and efficacy data are not disclosed in the snippet.
-
FDA approval · 2020-06-15FDA Approved: SIMVASTATIN — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for simvastatin from Micro Labs Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-06-12FDA Approved: FENOFIBRATE — Original Application (NorthStar RxLLC)
FDA approved NorthStar RxLLC's fenofibrate Original Application (ANDA213864), authorizing a generic fenofibrate product. This marks an appro…
-
FDA label_change · 2020-06-05FDA Approved: FLUVASTATIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA supplemental application for Fluvastatin submitted by Teva Pharmaceuticals USA, Inc. related to labeling changes.
-
FDA approval · 2020-05-21FDA Approved: CRESTOR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a Supplemental Application for CRESTOR (rosuvastatin) submitted by AstraZeneca Pharmaceuticals LP, updating the drug's labe…
-
FDA approval · 2020-05-12FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2020-05-12FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2020-05-05FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Simvastatin from NorthStar Rx LLC, approving the continued marketing of this generic statin.
-
FDA label_change · 2020-04-17FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for EZALLOR SPRINKLE (rosuvastatin), updating the product label as part of a supplemental submission…
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C [Phase 2]
Phase 2 trial evaluating a fixed-dose combination of bempedoic acid and ezetimibe in patients with type 2 diabetes and elevated LDL-C has co…
-
FDA approval · 2020-04-07FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's supplemental application for ROSUVASTATIN CALCIUM, a generic rosuvastatin calcium product, under approved …
-
FDA approval · 2020-04-07FDA Approved: ROSUVASTATIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for rosuvastatin from Camber Pharmaceuticals, a generic rosuvastatin product under an ANDA.
-
FDA approval · 2020-04-06FDA Approved: CHOLESTYRAMINE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA's original application for a generic cholestyramine product.
-
FDA approval · 2020-03-18FDA Approved: FENOFIBRATE — Original Application (Laurus Labs Limited)
The FDA approved Laurus Labs Limited's original application for a generic fenofibrate product, granting approval for a generic version of fe…
-
FDA approval · 2020-03-16FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)
The FDA approved a supplemental application for colesevelam hydrochloride (Glenmark Pharmaceuticals Inc., USA), updating the product's label…
-
FDA approval · 2020-03-16FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Colesevelam hydrochloride by Ascend Laboratories, LLC.
-
FDA approval · 2020-03-12FDA Approved: ROSUVASTATIN — Supplemental Application (Accord Healthcare Inc.)
FDA approved the supplemental application for rosuvastatin from Accord Healthcare Inc., extending approval for the generic rosuvastatin prod…
-
FDA approval · 2020-03-10FDA Approved: PRALUENT — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
FDA approved a supplemental application for Praluent (alirocumab) from Regeneron, enabling updated labeling for the drug.
-
FDA approval · 2020-03-10FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Cadila Pharmaceuticals Limited)
FDA approved the supplemental application for Rosuvastatin Calcium submitted by Cadila Pharmaceuticals Limited.
-
FDA approval · 2020-03-09FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Rosuvastatin Calcium from Torrent Pharmaceuticals Limited, expanding regulatory approval for thi…
-
FDA approval · 2020-03-09FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Glenmark Pharmaceutials Inc., USA)
FDA approved Glenmark's supplemental application for rosuvastatin calcium, authorizing a generic rosuvastatin calcium product and expanding …
-
FDA approval · 2020-03-09FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approves Westminster Pharmaceuticals' supplemental application for rosuvastatin calcium, confirming this rosuvastatin salt as an approve…